iTernity GmbH

Based in Germany, iTernity GmbH provides innovative data storage, archiving, and protection solutions to tackle challenges of data growth and security, including threats from ransomware, for diverse industries globally. iTernity GmbH, founded in 2004 and headquartered in Freiburg, Germany, specializes in data management solutions. The company has not gone through significant pivots or changes in its business model and does not have any subsidiaries. The founder's history is not publicly detailed.

iTernity has engaged in a single funding deal, with the most recent one occurring on July 29, 2025, when it was acquired by Biomedion GmbH, a portfolio company of Main Capital Partners. iTernity specializes in data storage, archiving, and protection solutions that address data growth, regulatory compliance, and security threats such as ransomware. Its core products include the iCAS FS scale-out storage platform and iCAS middleware, designed for secure, cost-effective storage of large data volumes. The iCAS FS platform is recognized as 'Veeam Ready,' providing immutable backups and serving as a secure backup storage and audit-proof archiving solution.

These offerings cater to various sectors, including healthcare, manufacturing, financial services, and public sectors, with clients across Europe, North America, and parts of Asia. iTernity's solutions enhance data integrity, availability, and reduce complexity and costs associated with large volumes of critical data. iTernity generates revenue primarily through business-to-business transactions, offering subscription-based services and solutions. Clients enter multi-year contracts for continuous access to iTernity's software and support services, including iCAS FS and iCAS middleware.

Revenue is generated from licensing fees for software use, along with additional charges for support and maintenance services, which align with clients' data storage needs. The company's robust partner ecosystem contributes to its revenue through collaborative projects that integrate complementary technologies. With the acquisition by Biomedion GmbH on July 29, 2025, financial terms undisclosed, iTernity aims to strengthen its compliance data solutions and leverage the new parent company's resources for growth. The acquisition will support the next phase of growth in enhancing data management solutions, focusing on innovative product development and potential market expansions.